Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung
- Conditions
- Lung Cancer (NSCLC)Lung Cancer (SCLC)
- Registration Number
- NCT07202260
- Lead Sponsor
- The Christie NHS Foundation Trust
- Brief Summary
This study focuses on improving care for people with lung cancer who face unusual or complex treatment situations.
- Detailed Description
By studying detailed patient data, researchers aim to find the best ways to treat these patients while reducing short- and long-term side effects. The findings will help refine radiotherapy treatments, ensuring they are as safe and effective as possible. Additionally, the results will provide doctors with better information to help patients understand the potential risks and benefits of their treatment options.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 80
Complex patients with lung cancer undergoing radiotherapy in one of the following groups;
- Rare histology
- Disease invading vascular structures
- Co-existing interstitial lung disease (ILD)
- Radical re-irradiation
- Oligopersistent/oligoprogressive disease on immunotherapy or targeted therapies.
- Include patients with stage IV disease who are receiving non-curative intent radiotherapy
- There are no exclusion criteria relating to upper age limit or comorbidities.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acute and late toxicity 2 years \- Acute (\<90 days post radiotherapy) and late (\> 90 days post radiotherapy) toxicity according to common terminology criteria for adverse events (CTCAE) V5.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The Christie NHS Foundation Trust
🇬🇧Withington, Greater Manchester, United Kingdom
The Christie NHS Foundation Trust🇬🇧Withington, Greater Manchester, United Kingdom